How does Alocuro PRP medical devices compare with other PRP kits? 

Superior PRP efficiency 

Alocuro’s PRP device and preparation protocol has demonstrated outstanding performance in extracting, separating, and collecting PRP from patient’s blood with documented platelet concentration of up to a multiple of 12.8x platelet concentration above baseline level, and a platelet recovery efficiency of 90-95%. This efficiency is significantly superior to other manual preparation PRP kits currently available in Australia.

Leukocyte-reduced PRP and leukocyte-rich prp are achievable with Alocuro’s system

Leukocyte-reduced PRP and leukocyte-rich PRP can be prepared using the one Alocuro system.

Intact, non-activated Platelets for optimal release of growth factors upon injection 

Apart from standard anti-coagulation with CPDA, Alocuro PRP does not require the use of any foreign material e.g. activation material or thixotropic separation gel to separate the cellular components. This ensures that the patient is receiving a pure, unaltered by chemicals, autologous blood product, which minimises the risk of reaction to and complications from the PRP injection. In-situ activation of platelets by exposure to collagen at the target site is beneficial for stimulating a more sustained healing response due to slower release of growth factors.

Parameters that need to be included for comparative optimisation of PRP preparation protocols include:

  • the absolute number and concentration of platelets over baseline - should be ideally at least 3X

  • the absolute number and concentration of leukocytes / WBC below baseline, should be physiological baseline or less

  • the absolute number and concentration of RBC below physiological baseline- should ideally be nil

  • the choice between exogenous pre-activation of platelets or not,

  • the number of injections

  • and the interval between injections

Need a PRP protocol that:

  • standardises the preparation of PRP

  • emphasis on overall preservation of platelets’ physiological properties until time of injection

  • reproducible in any clinical setting

  • cost-effective delivery of growth factors